The 10th International Conference on cGMP 2022: recent trends in cGMP research and development-meeting report.

Journal Information

Full Title: Naunyn Schmiedebergs Arch Pharmacol

Abbreviation: Naunyn Schmiedebergs Arch Pharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Competing interestsThe authors declare no competing interests. Ethical approvalReview article/non-applicable. Conflict of interestAF, MR, and AS declare that they have no competing interests. PS and JRK are full-time employees of Bayer AG, Pharmaceuticals. Competing interests The authors declare no competing interests. Conflict of interest AF, MR, and AS declare that they have no competing interests. PS and JRK are full-time employees of Bayer AG, Pharmaceuticals."

Evidence found in paper:

"Funding The 10th cGMP meeting 2022 was financially supported by the Platin Sponsors, the Deutsche Forschungsgemeinschaft (DFG), Bayer AG, and Merck Sharp & Dohme Corp (MSD); the Gold Sponsor, Cyclerion; and the Corporate Sponsors, Bio Log, DSI, Biomol, Eppendorf, and Zeiss. Research related on cGMP signaling in the labs of AF, MR and AS are funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation – FR 1725/3-2, RU 1413/2-1 and SCHM 2629/4-1). "

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025